Developer docs
API playgroundTry for free, no card

Search company profiles

Nu-Tek Bioscience

Full company profile

uuid000hodu

Namestring
Nu-Tek Bioscience
Legal namestring
Nu-Tek Biosciences, LLC
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Nu-Tek BioSciences is a privately held U.S. manufacturer specializing in 100% animal-origin-free peptones, yeast extracts, and hydrolysates used as raw materials in biopharmaceutical cell culture and microbial fermentation. The company's products — soy peptones, pea peptones, wheat hydrolysates, yeast extracts, and supplemented cell culture media — target biologic drug manufacturers producing vaccines and therapeutics, where animal-derived raw materials carry contamination risk and regulatory burden. Nu-Tek positions itself as the market leader in this animal-free niche, operating what it describes as the only completely animal-free manufacturing facility in the United States, located in Austin, Minnesota, with corporate headquarters in Minnetonka.

The company's core technology is a plant-based biomanufacturing platform with three proprietary capabilities: (i) the Variability Reduction Program, a collaborative development offering that pairs Nu-Tek experts with biotech customers to define critical material attributes and ensure consistent, scalable production; (ii) fit-for-function product design, where each peptone, yeast extract, and hydrolysate is customized to customer specifications from manufacturing through packaging; and (iii) a U.S.-based supply chain positioned as a security and resilience advantage for biologic manufacturers seeking to reduce foreign dependency.

Nu-Tek operates a B2B enterprise field sales motion, selling directly to global pharmaceutical and biotechnology manufacturers through long-term supply partnerships rather than disclosed pricing or catalog sales. Pricing is quote-based and not publicly disclosed. Commercial activity is anchored at major biopharma industry events (BIO International Convention, ESACT, DCAT Week) and supported by content marketing, LinkedIn, and Facebook presence. The company is led by founder, CEO, and President Tom Yezzi, and is capitalized privately as Nu-Tek Biosciences, LLC, with a $4.5M financing round from healthcare-specialist investor 1315 Capital closed in July 2025.

Short descriptiontext

Nu-Tek BioSciences manufactures 100% animal-origin-free peptones, yeast extracts, and hydrolysates for global biopharmaceutical companies producing vaccines, therapeutics, and biologics, operating the only fully animal-free manufacturing facility in the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMinnetonka, United States
HQ citystring
Minnetonka
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal-free peptones, yeast extracts manufacturing, protein hydrolysates, cell culture media, biopharmaceutical raw materials
Industry3 codes
PRIMARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Biopharmaceutical Specialty Ingredients
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Animal-Free Specialty Ingredients Sales
TypeOne Time License
Description

Sale of 100% animal-origin-free peptones, yeast extracts, and hydrolysates to biopharmaceutical and biotechnology manufacturers for use in cell culture and microbial fermentation applications supporting vaccine and therapeutic production.

nu-tekbiosciences.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nu-Tek BioSciences develops and manufactures 100% animal-origin-free specialty peptones, yeast extracts, and protein hydrolysates used as raw materials in cell culture media and microbial fermentation for biopharmaceutical manufacturers. The company complements these ingredients with cell culture media formulations, a collaborative Variability Reduction Program for defining critical material attributes, and custom manufacturing and packaging services tailored to customer specifications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Nu-Tek BioSciences is a market leader in 100% animal-origin-free specialty yeast extracts, peptones, and hydrolysates for the biopharmaceutical industry. The company's product portfolio consists of four core biological ingredient product lines—Yeast Extracts, Soy Peptones, Pea Peptones, and Wheat Hydrolysates (Wheat Peptones)—along with Cell Culture Media offerings. These products support cell culture and microbial fermentation applications for vaccine and therapeutic production. The company also offers a Variability Reduction Program to help biotech developers define critical material attributes and ensure consistent, scalable production, and provides Custom Manufacturing services for product customization from manufacturing to packaging.

Product and service7 records
1Yeast Extracts
CategoryCore Product
Description

100% animal-origin-free specialty yeast extracts used as nutrients in cell culture media and microbial fermentation for biopharmaceutical production, including vaccine and therapeutic manufacturing.

2Soy Peptones
CategoryCore Product
Description

Plant-based soy peptones providing animal-free nitrogen sources for cell culture and fermentation applications in vaccine and therapeutic production.

3Pea Peptones
CategoryCore Product
Description

Plant-based pea peptones serving as sustainable, animal-origin-free nitrogen sources for biopharmaceutical cell culture and fermentation processes.

4Wheat Hydrolysates (Wheat Peptones)
CategoryCore Product
Description

Plant-based wheat hydrolysates providing animal-free nutrients for cell culture media and microbial fermentation in biopharmaceutical manufacturing.

5Cell Culture Media
CategoryCore Product
Description

Animal-origin-free cell culture media formulations supplemented with Nu-Tek's specialty peptones and yeast extracts, designed for vaccine and therapeutic production.

6Variability Reduction Program
CategoryService/Program
Description

Collaborative development program pairing biotech developers with Nu-Tek experts to define critical material attributes and ensure consistent, scalable production with reduced variability in bioprocess inputs.

7Custom Manufacturing
CategoryService
Description

Customized manufacturing and packaging services for peptones, yeast extracts, and hydrolysates tailored to specific customer production requirements, from raw material to packaged product.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Kerry's Bio-Science division is one of the largest global producers of yeast extracts and peptones for cell culture and fermentation, serving the same biopharma customers as Nu-Tek with comparable animal-free and plant-based ingredients.

TypeBroad incumbent
Description

BD's Difco and Bacto brands are heritage peptone product lines used globally in cell culture and microbial fermentation. BD is a much larger incumbent offering broad bioprocess inputs alongside Nu-Tek's specialized animal-free range.

TypeBroad incumbent
Description

Through its Gibco brand, Thermo Fisher is the dominant global supplier of cell culture media, sera, and peptones for biopharma manufacturing — directly addressing the same end-customer need that Nu-Tek's animal-free peptones target.

TypeDirect peer
Description

Ohly specializes in yeast extracts and peptones for fermentation and cell culture applications, with a strong focus on plant-based and non-animal ingredients — a directly overlapping product portfolio with Nu-Tek's specialty yeast extracts.

TypeDirect peer
Description

Irvine Scientific is a dedicated cell culture media manufacturer offering chemically-defined and animal-component-free media for vaccine, cell therapy, and biotherapeutic production — competing head-on with Nu-Tek's animal-free bioprocess inputs.

TypeDirect peer
Description

Bio-Techne (R&D Systems, PeproTech) supplies cell culture reagents, proteins, and media components to biopharma developers. Its specialty ingredients and custom media services overlap with Nu-Tek's cell culture media and peptone portfolio.

TypeBroad incumbent
Description

Cytiva is a global bioprocess solutions provider offering cell culture media, buffers, and process ingredients alongside its core filtration and chromatography portfolio — competing broadly with Nu-Tek in upstream bioprocess inputs.

TypeBroad incumbent
Description

Sartorius' Bioprocess Solutions division supplies cell culture media, fermentation nutrients, and process services to biopharma manufacturers — a large incumbent addressing the same upstream bioprocess inputs market as Nu-Tek.

9BioSpringer (Lesaffre)
TypeDirect peer
Description

BioSpringer, part of Lesaffre, is a major global producer of yeast extracts and peptones for fermentation and cell culture applications. It competes directly with Nu-Tek in animal-free and plant-based bioprocess ingredients.

TypeBroad incumbent
Description

Lonza offers cell culture media, custom media development, and bioprocess services to global biopharma customers. Its cell and gene therapy media portfolio overlaps with Nu-Tek's animal-free cell culture media offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nu-Tek Bioscience

Biopharmaceutical Specialty Ingredientsnu-tekbioscience.com

Nu-Tek BioSciences manufactures 100% animal-origin-free peptones, yeast extracts, and hydrolysates for global biopharmaceutical companies producing vaccines, therapeutics, and biologics, operating the only fully animal-free manufacturing facility in the United States.

What Nu-Tek Bioscience does

Nu-Tek BioSciences is a privately held U.S. manufacturer specializing in 100% animal-origin-free peptones, yeast extracts, and hydrolysates used as raw materials in biopharmaceutical cell culture and microbial fermentation. The company's products — soy peptones, pea peptones, wheat hydrolysates, yeast extracts, and supplemented cell culture media — target biologic drug manufacturers producing vaccines and therapeutics, where animal-derived raw materials carry contamination risk and regulatory burden. Nu-Tek positions itself as the market leader in this animal-free niche, operating what it describes as the only completely animal-free manufacturing facility in the United States, located in Austin, Minnesota, with corporate headquarters in Minnetonka.

The company's core technology is a plant-based biomanufacturing platform with three proprietary capabilities: (i) the Variability Reduction Program, a collaborative development offering that pairs Nu-Tek experts with biotech customers to define critical material attributes and ensure consistent, scalable production; (ii) fit-for-function product design, where each peptone, yeast extract, and hydrolysate is customized to customer specifications from manufacturing through packaging; and (iii) a U.S.-based supply chain positioned as a security and resilience advantage for biologic manufacturers seeking to reduce foreign dependency.

Nu-Tek operates a B2B enterprise field sales motion, selling directly to global pharmaceutical and biotechnology manufacturers through long-term supply partnerships rather than disclosed pricing or catalog sales. Pricing is quote-based and not publicly disclosed. Commercial activity is anchored at major biopharma industry events (BIO International Convention, ESACT, DCAT Week) and supported by content marketing, LinkedIn, and Facebook presence. The company is led by founder, CEO, and President Tom Yezzi, and is capitalized privately as Nu-Tek Biosciences, LLC, with a $4.5M financing round from healthcare-specialist investor 1315 Capital closed in July 2025.

Nu-Tek Bioscience firmographics

Firmographics
Name
Nu-Tek Bioscience
Legal name
Nu-Tek Biosciences, LLC
Website
https://nu-tekbioscience.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Nu-Tek BioSciences manufactures 100% animal-origin-free peptones, yeast extracts, and hydrolysates for global biopharmaceutical companies producing vaccines, therapeutics, and biologics, operating the only fully animal-free manufacturing facility in the United States.
Ownership category
akta.pro rank

Nu-Tek Bioscience industry classification

Industry
Product category
Biopharmaceutical Specialty Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Animal-free peptones
  • Yeast extracts manufacturing
  • Protein hydrolysates
  • Cell culture media
  • Biopharmaceutical raw materials

Where Nu-Tek Bioscience is headquartered

Location

Headquarters

HQ city
Minnetonka
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Nu-Tek Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Animal-Free Specialty Ingredients Sales: Sale of 100% animal-origin-free peptones, yeast extracts, and hydrolysates to biopharmaceutical and biotechnology manufacturers for use in cell culture and microbial fermentation applications supporting vaccine and therapeutic production.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Nu-Tek Bioscience product offering

Product offering

Core offering

Nu-Tek BioSciences develops and manufactures 100% animal-origin-free specialty peptones, yeast extracts, and protein hydrolysates used as raw materials in cell culture media and microbial fermentation for biopharmaceutical manufacturers. The company complements these ingredients with cell culture media formulations, a collaborative Variability Reduction Program for defining critical material attributes, and custom manufacturing and packaging services tailored to customer specifications.

Product overview

Nu-Tek BioSciences is a market leader in 100% animal-origin-free specialty yeast extracts, peptones, and hydrolysates for the biopharmaceutical industry. The company's product portfolio consists of four core biological ingredient product lines—Yeast Extracts, Soy Peptones, Pea Peptones, and Wheat Hydrolysates (Wheat Peptones)—along with Cell Culture Media offerings. These products support cell culture and microbial fermentation applications for vaccine and therapeutic production. The company also offers a Variability Reduction Program to help biotech developers define critical material attributes and ensure consistent, scalable production, and provides Custom Manufacturing services for product customization from manufacturing to packaging.

Differentiator

Problem solved

Functional benefit

Products and services

  • Yeast Extracts 100% animal-origin-free specialty yeast extracts used as nutrients in cell culture media and microbial fermentation for biopharmaceutical production, including vaccine and therapeutic manufacturing.
  • Soy Peptones Plant-based soy peptones providing animal-free nitrogen sources for cell culture and fermentation applications in vaccine and therapeutic production.
  • Pea Peptones Plant-based pea peptones serving as sustainable, animal-origin-free nitrogen sources for biopharmaceutical cell culture and fermentation processes.
  • Wheat Hydrolysates (Wheat Peptones) Plant-based wheat hydrolysates providing animal-free nutrients for cell culture media and microbial fermentation in biopharmaceutical manufacturing.
  • Cell Culture Media Animal-origin-free cell culture media formulations supplemented with Nu-Tek's specialty peptones and yeast extracts, designed for vaccine and therapeutic production.
  • Variability Reduction Program Collaborative development program pairing biotech developers with Nu-Tek experts to define critical material attributes and ensure consistent, scalable production with reduced variability in bioprocess inputs.
  • Custom Manufacturing Customized manufacturing and packaging services for peptones, yeast extracts, and hydrolysates tailored to specific customer production requirements, from raw material to packaged product.

Companies that use Nu-Tek Bioscience

Customer profile

Segments2 records

Ideal customer profiles2 records

Nu-Tek Bioscience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Nu-Tek Bioscience partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Nu-Tek Bioscience competitors and assessment

Company assessment

Direct peers

  • Kerry Group: Kerry's Bio-Science division is one of the largest global producers of yeast extracts and peptones for cell culture and fermentation, serving the same biopharma customers as Nu-Tek with comparable animal-free and plant-based ingredients.
  • Ohly (Südzucker Group): Ohly specializes in yeast extracts and peptones for fermentation and cell culture applications, with a strong focus on plant-based and non-animal ingredients — a directly overlapping product portfolio with Nu-Tek's specialty yeast extracts.
  • FUJIFILM Irvine Scientific: Irvine Scientific is a dedicated cell culture media manufacturer offering chemically-defined and animal-component-free media for vaccine, cell therapy, and biotherapeutic production — competing head-on with Nu-Tek's animal-free bioprocess inputs.
  • Bio-Techne: Bio-Techne (R&D Systems, PeproTech) supplies cell culture reagents, proteins, and media components to biopharma developers. Its specialty ingredients and custom media services overlap with Nu-Tek's cell culture media and peptone portfolio.
  • BioSpringer (Lesaffre): BioSpringer, part of Lesaffre, is a major global producer of yeast extracts and peptones for fermentation and cell culture applications. It competes directly with Nu-Tek in animal-free and plant-based bioprocess ingredients.

Broad incumbents

  • BD Biosciences: BD's Difco and Bacto brands are heritage peptone product lines used globally in cell culture and microbial fermentation. BD is a much larger incumbent offering broad bioprocess inputs alongside Nu-Tek's specialized animal-free range.
  • Thermo Fisher Scientific: Through its Gibco brand, Thermo Fisher is the dominant global supplier of cell culture media, sera, and peptones for biopharma manufacturing — directly addressing the same end-customer need that Nu-Tek's animal-free peptones target.
  • Cytiva (Danaher): Cytiva is a global bioprocess solutions provider offering cell culture media, buffers, and process ingredients alongside its core filtration and chromatography portfolio — competing broadly with Nu-Tek in upstream bioprocess inputs.
  • Sartorius: Sartorius' Bioprocess Solutions division supplies cell culture media, fermentation nutrients, and process services to biopharma manufacturers — a large incumbent addressing the same upstream bioprocess inputs market as Nu-Tek.
  • Lonza Group: Lonza offers cell culture media, custom media development, and bioprocess services to global biopharma customers. Its cell and gene therapy media portfolio overlaps with Nu-Tek's animal-free cell culture media offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Nu-Tek Bioscience social profiles

Digital presence

Nu-Tek Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nu-Tek Bioscience leadership team

Management profile

Number of profiles

Profiles1 record

Nu-Tek Bioscience funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nu-Tek Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nu-Tek Bioscience

What does Nu-Tek Bioscience do?

Nu-Tek BioSciences develops and manufactures 100% animal-origin-free specialty peptones, yeast extracts, and protein hydrolysates used as raw materials in cell culture media and microbial fermentation for biopharmaceutical manufacturers. The company complements these ingredients with cell culture media formulations, a collaborative Variability Reduction Program for defining critical material attributes, and custom manufacturing and packaging services tailored to customer specifications.

Is Nu-Tek Bioscience a public or private company?

Nu-Tek Bioscience is a private company. It is classified as venture growth investor backed and is currently operating.

When was Nu-Tek Bioscience founded?

Nu-Tek Bioscience was founded in 2009. It employs 11 to 50 people.

Where is Nu-Tek Bioscience based?

Nu-Tek Bioscience is headquartered in Minnetonka, United States, in the North America region.

How does Nu-Tek Bioscience make money?

One revenue line is on record: animal-Free Specialty Ingredients Sales.

Who are Nu-Tek Bioscience's main competitors?

Direct peers on record are Kerry Group, Ohly (Südzucker Group), FUJIFILM Irvine Scientific, Bio-Techne and BioSpringer (Lesaffre). Broad incumbents are BD Biosciences, Thermo Fisher Scientific, Cytiva (Danaher), Sartorius and Lonza Group.

Does Nu-Tek Bioscience have an API?

No public API is recorded for Nu-Tek Bioscience.

What industry is Nu-Tek Bioscience in?

Nu-Tek Bioscience's product category is Biopharmaceutical Specialty Ingredients. Its primary akta.pro industry code is EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives, with a secondary code of AFAJAHAL, Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinanzNachrichten.deNu-Tek Biosciences, LLC: Nu-Tek BioSciences hat die Überprüfung der ISO 9001-Zertifizierung erfolgreich abgeschlossen und bekräftigt damit sein Engagement für die Qualität der RohstoffeNu-Tek BioSciences successfully completed its latest ISO 9001 certification audit, reaffirming its commitment to quality management and consistent manufacturing quality. The company, a leader in 100% animal-free peptones and protein hydrolysates, has held the certification since 2019 and continues to undergo surveillance audits.The future of tradingNu-Tek BioSciences Successfully Completes ISO 9001 Certification Review, Reinforcing Commitment to Raw Material QualityNu-Tek BioSciences completed its latest ISO 9001 certification review, reaffirming its commitment to quality management and manufacturing consistency. The company, a leader in animal-origin-free peptones and protein hydrolysates, has held certification since 2019 and continues surveillance audits. The certification supports biopharmaceutical customers' supplier evaluation requirements.FinanzNachrichten.deNu-Tek Biosciences, LLC: Nu-Tek BioSciences präsentiert auf der SIMB 2026 Innovationen im Bereich Zellnährstoffe und sein Fachwissen zu RohstoffenNu-Tek BioSciences, a leader in 100% animal-free peptones and protein hydrolysates, will present new data at the SIMB 2026 conference in Austin, Texas from August 2-5, 2026, showcasing how their animal-free culture media nutrients improve yield, optimize processes, and strengthen supply security in bioproduction. The company will present a poster on plant-based hydrolysates as replacements for animal-derived components in common fermentation media formulations, targeting industry leaders in bioprocessing, vaccines, biologics, and therapeutics. Nu-Tek positions its offerings as enabling customers to drive innovation and production success through its Variability Reduction Program and collaborative raw material customization approach.GlobeNewswireNu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026Nu-Tek BioSciences announced its participation in the BIO International Convention 2026, taking place June 22–25 in San Diego, as part of the Minnesota Pavilion hosted by the Minnesota Department of Employment and Economic Development. The company, a leader in animal-origin-free peptones and yeast extracts, will showcase its Variability Reduction Program designed to help biotech innovators scale production while maintaining consistent raw material quality. CEO Tom Yezzi emphasized the company's focus on providing a predictable, scalable manufacturing platform with a secure U.S.-based supply chain.GlobeNewswireNu-Tek BioSciences accélère la révolution des matières premières sans origine animale et rejoint le pavillon du Minnesota #4507 au salon BIO 2026Nu-Tek BioSciences announced its participation in the Minnesota pavilion at BIO 2026 to showcase its animal-origin-free biotechnological products and its Variability Reduction Program. The company provides high-quality, animal-free peptides and yeast extracts, supporting biopharmaceutical and cell culture industries from its Minnetonka facility. Nu-Tek emphasizes supply chain security and collaborative development to meet the needs of biotechnological innovators.GlobeNewswireNu-Tek BioSciences treibt die Revolution im Bereich tierfreier Rohstoffe voran, Teil des Minnesota Pavilion #4507 auf der BIO 2026Nu-Tek BioSciences announced its participation in the BIO International Convention from June 22–25 in San Diego, California, as part of the Minnesota Pavilion organized by the Minnesota Department of Employment and Economic Development. The company showcased its portfolio of 100% animal-origin-free peptones and yeast extracts along with its Variability Reduction Program, which pairs biotech developers with Nu-Tek experts to define critical material attributes and ensure consistent, scalable production. Nu-Tek BioSciences, headquartered in Minnetonka, Minnesota, positions itself as a market leader in animal-free raw materials for the biopharmaceutical industry, including cell culture and microbial fermentation supporting vaccine and therapeutic production.GlobeNewswireNu-Tek BioSciences Presents Data-Driven Approach to Animal Cell Culture Optimization at ESACT 2026Nu-Tek BioSciences will exhibit at ESACT 2026, presenting a poster on its Variability Reduction Program. The poster highlights data on improving cell culture performance and controlling costs through collaboration. The company invites attendees to visit Booth 23 for meetings.GlobeNewswireNu-Tek BioSciences présente une approche fondée sur les données pour l’optimisation de la culture de cellules animales lors de l’ESACT 2026Nu-Tek BioSciences will present a poster at ESACT 2026, showcasing its data-driven variability-reduction program for animal cell culture. The poster highlights how collaboration with pharmaceutical and biotech clients improves culture performance and cost control. The company will also display its animal-free peptones and nutrients at stand 23.Business Wire BlogNu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC RegionsNu-Tek BioSciences signed a distribution agreement with IMCD to sell its peptones and hydrolysates in Europe and Asia Pacific. The partnership expands Nu-Tek's reach and solidifies its position as a market leader in animal-free ingredients. IMCD will enable Nu-Tek to serve local customers and expand its product line.